LifeStyle Sleeping less than 6 hours cuts cognitive benefits of exercise: Lancet study Taner Halicioglu Jul 8, 2023 By PTI NEW DELHI: Sleeping for less than six hours daily may cut down the protective effect of… Read More...
LifeStyle Alarming rise in global population of men with enlarged prostate: Lancet Taner Halicioglu Mar 23, 2023 Express News Service NEW DELHI: There has been an alarming hike in benign prostatic hyperplasia… Read More...
LifeStyle Symptoms of long Covid in children may change over time: Lancet study Taner Halicioglu Mar 22, 2023 By PTI LONDON: Symptoms of long Covid experienced by children and young people may change over… Read More...
LifeStyle Formula milk sales pitch is at expense of women, children’s health: Report Taner Halicioglu Mar 19, 2023 By Express News Service NEW DELHI: Formula milk manufacturers have come out with a highly… Read More...
LifeStyle Formula milk companies use exploitative tactics to undermine breastfeeding: Lancet series Taner Halicioglu Mar 18, 2023 By PTI NEW DELHI: The formula milk industry's marketing tactics are exploitative and undermine… Read More...
LifeStyle Childhood pneumonia linked with higher death risk from respiratory infection as adult: Lancet study Taner Halicioglu Mar 17, 2023 By PTI LONDON: Respiratory infections contracted during early childhood are associated with an… Read More...
LifeStyle Childhood pneumonia linked with higher death risk from respiratory infection as adult: Lancet study Taner Halicioglu Mar 8, 2023 By PTI LONDON: Respiratory infections contracted during early childhood are associated with an… Read More...
LifeStyle Formula milk companies use exploitative tactics to undermine breastfeeding: Lancet series Taner Halicioglu Feb 14, 2023 By PTI NEW DELHI: The formula milk industry's marketing tactics are exploitative and undermine… Read More...
LifeStyle Formula milk sales pitch is at expense of women, children’s health: Report Taner Halicioglu Feb 9, 2023 By Express News Service NEW DELHI: Formula milk manufacturers have come out with a highly… Read More...
Health 89bio Announces Publication of Results of Phase 1b/2a Study of Pegozafermin for the Treatment of… James Pereira Dec 13, 2022 – Data from cohorts 1-6 in the proof-of-concept study showed pegozafermin was generally well tolerated and had… Read More...